MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,441,980 | -36.9% | 89,899 | -8.9% | 0.00% | -33.3% |
| Q2 2023 | $2,286,267 | -2.3% | 98,631 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $2,341,026 | +58.4% | 100,776 | -1.1% | 0.00% | +50.0% |
| Q4 2022 | $1,477,931 | -22.9% | 101,856 | +1.3% | 0.00% | -33.3% |
| Q3 2022 | $1,918,000 | +3.1% | 100,537 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $1,861,000 | -27.5% | 102,401 | +0.6% | 0.00% | 0.0% |
| Q1 2022 | $2,566,000 | -14.9% | 101,824 | -6.8% | 0.00% | -25.0% |
| Q4 2021 | $3,014,000 | -11.0% | 109,200 | +4.1% | 0.00% | 0.0% |
| Q3 2021 | $3,388,000 | +5.0% | 104,909 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $3,228,000 | -1.3% | 105,569 | -1.7% | 0.00% | 0.0% |
| Q1 2021 | $3,269,000 | +52.4% | 107,349 | -1.0% | 0.00% | +33.3% |
| Q4 2020 | $2,145,000 | +51.2% | 108,467 | -0.3% | 0.00% | +50.0% |
| Q3 2020 | $1,419,000 | +15.0% | 108,819 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,234,000 | -19.7% | 108,819 | +1.3% | 0.00% | -33.3% |
| Q1 2020 | $1,537,000 | -48.0% | 107,414 | -1.1% | 0.00% | -40.0% |
| Q4 2019 | $2,958,000 | -5.8% | 108,626 | -0.9% | 0.01% | -16.7% |
| Q3 2019 | $3,139,000 | +4.6% | 109,654 | +1.5% | 0.01% | 0.0% |
| Q2 2019 | $3,000,000 | -14.2% | 108,002 | +2.6% | 0.01% | -14.3% |
| Q1 2019 | $3,496,000 | +9.5% | 105,290 | -4.1% | 0.01% | 0.0% |
| Q4 2018 | $3,192,000 | -31.8% | 109,819 | +8.0% | 0.01% | -22.2% |
| Q3 2018 | $4,678,000 | +24.7% | 101,705 | +1.3% | 0.01% | +12.5% |
| Q2 2018 | $3,752,000 | +27.7% | 100,408 | +1.0% | 0.01% | +33.3% |
| Q1 2018 | $2,939,000 | -16.9% | 99,448 | -3.4% | 0.01% | -14.3% |
| Q4 2017 | $3,535,000 | -5.0% | 102,935 | +0.1% | 0.01% | -12.5% |
| Q3 2017 | $3,720,000 | +26.5% | 102,832 | -9.6% | 0.01% | +33.3% |
| Q2 2017 | $2,940,000 | +15.2% | 113,770 | -14.4% | 0.01% | +20.0% |
| Q1 2017 | $2,553,000 | +10.0% | 132,971 | -4.5% | 0.01% | 0.0% |
| Q4 2016 | $2,320,000 | -21.1% | 139,171 | -2.6% | 0.01% | -16.7% |
| Q3 2016 | $2,940,000 | -32.2% | 142,871 | +0.8% | 0.01% | -33.3% |
| Q2 2016 | $4,338,000 | -21.5% | 141,771 | -3.9% | 0.01% | -25.0% |
| Q1 2016 | $5,523,000 | -0.6% | 147,562 | +14.7% | 0.01% | -14.3% |
| Q4 2015 | $5,555,000 | +16.9% | 128,699 | +1.5% | 0.01% | +16.7% |
| Q3 2015 | $4,750,000 | +10.2% | 126,743 | -0.1% | 0.01% | +20.0% |
| Q2 2015 | $4,311,000 | -11.5% | 126,843 | -7.8% | 0.01% | -16.7% |
| Q1 2015 | $4,870,000 | +2.4% | 137,557 | -1.5% | 0.01% | +9.1% |
| Q4 2014 | $4,757,000 | -11.1% | 139,652 | +0.7% | 0.01% | -15.4% |
| Q3 2014 | $5,348,000 | -0.7% | 138,660 | +0.2% | 0.01% | -7.1% |
| Q2 2014 | $5,388,000 | +16.0% | 138,442 | +1.9% | 0.01% | +16.7% |
| Q1 2014 | $4,644,000 | +63.6% | 135,842 | +0.4% | 0.01% | +50.0% |
| Q4 2013 | $2,839,000 | -15.7% | 135,342 | -5.5% | 0.01% | -20.0% |
| Q3 2013 | $3,366,000 | -9.8% | 143,242 | +3.2% | 0.01% | -16.7% |
| Q2 2013 | $3,730,000 | +4.8% | 138,805 | -0.9% | 0.01% | 0.0% |
| Q1 2013 | $3,559,000 | – | 140,133 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |